USAGE OF UTS BIOCIDAL MODULE AND EXTENSION OF LICENSE VALIDITY FOR BIOCIDAL PRODUCTS IN DIRECT CONTACT WITH THE HUMAN BODY (PRODUCT TYPE-1 AND PRODUCT TYPE-19)
Content addition date : 01-12-2021
With the announcement published by Turkish Medicines and Medical Devices Agency (TİTCK), It has been stated that as of 09.12.2021, registration applications for product type-1 and product type-19 biocidal products will be started via the ÜTS Biocidal Module.
In addition, the license validity period of product type-1 and product type-19 biocidal products licensed by the General Directorate of Public Health (HSGM) and expired the license on 31/12/2021, has been extended until 31/12/2022.
It has been stated that it is necessary to apply for a license evaluation with all the necessary documents related to the product through the ÜTS Biocidal Module and to complete the licensing process until the end of the period. The licenses of the companies that do not complete the license process by the end of this period will be cancelled.
For detailed information, you can find the related announcement here.
You can find the training guides here.
You can follow the updates regarding the ÜTS Biocidal Module here.
You can contact CRAD team for further details.